The chronic use of beta-blockers and proton pump inhibitors may affect the rate of bacterial infections in cirrhosis

Non-selective beta-blockers are not associated with serious infections in veterans with cirrhosis

(2013) J. S. Bajaj et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Outcomes of Patients Hospitalized With Community-Acquired, Health Care–Associated, and Hospital-Acquired Pneumonia

(2013) Mario Venditti   ANNALS OF INTERNAL MEDICINE

Microvascular Effects of Heart Rate Control With Esmolol in Patients With Septic Shock

(2013) Andrea Morelli et al.   CRITICAL CARE MEDICINE

Increased risk of cognitive impairment in cirrhotic patients with bacterial infections

(2013) Manuela Merli et al.   JOURNAL OF HEPATOLOGY

Role of proton pump inhibitors in the occurrence and the prognosis of spontaneous bacterial peritonitis in cirrhotic patients with ascites

(2013) Marie de Vos et al.   LIVER INTERNATIONAL

Modulation of the Metabiome by Rifaximin in Patients with Cirrhosis and Minimal Hepatic Encephalopathy

(2013) Jasmohan S. Bajaj et al.   PLoS One

The window hypothesis: haemodynamic and non-haemodynamic effects of β-blockers improve survival of patients with cirrhosis during a window in the disease: Figure 1

(2012) Aleksander Krag et al.   GUT

The Role of Rifaximin in the Primary Prophylaxis of Spontaneous Bacterial Peritonitis in Patients With Liver Cirrhosis

(2012) Mohamad A. Hanouneh et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis

(2012) Thomas Reiberger et al.   JOURNAL OF HEPATOLOGY

Increased Rate of Spontaneous Bacterial Peritonitis Among Cirrhotic Patients Receiving Pharmacologic Acid Suppression

(2011) Gati A. Goel et al.   Clinical Gastroenterology and Hepatology

Bacterial infections in cirrhosis: role of proton pump inhibitors and intestinal permeability

(2011) Lotte G. van Vlerken et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Association between proton pump inhibitors and spontaneous bacterial peritonitis in cirrhotic patients - a systematic review and meta-analysis

(2011) G. Trikudanathan et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: A cross-over study

(2011) Thomas Sersté et al.   JOURNAL OF HEPATOLOGY

Association between acid suppressive therapy and spontaneous bacterial peritonitis in cirrhotic patients with ascites

(2011) Eun Jung Choi et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Meta-analysis: proton pump inhibitor use and the risk of community-acquired pneumonia

(2010) J. JOHNSTONE et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Cirrhotic Patients Are at Risk for Health Care–Associated Bacterial Infections

(2010) Manuela Merli et al.   Clinical Gastroenterology and Hepatology

Increased Incidence of Small Intestinal Bacterial Overgrowth During Proton Pump Inhibitor Therapy

(2010) Lucio Lombardo et al.   Clinical Gastroenterology and Hepatology

Prevalence and appropriateness of drug prescriptions for peptic ulcer and gastro-esophageal reflux disease in a cohort of hospitalized elderly

(2010) L. Pasina et al.   European Journal of Internal Medicine

Infections in Patients With Cirrhosis Increase Mortality Four-Fold and Should Be Used in Determining Prognosis

(2010) Vasiliki Arvaniti et al.   GASTROENTEROLOGY

Splanchnic sympathectomy prevents translocation and spreading of E coli but not S aureus in liver cirrhosis

(2010) M. Worlicek et al.   GUT

Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites

(2010) Thomas Sersté et al.   HEPATOLOGY

Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy

(2010) Ankur Gupta et al.   JOURNAL OF HEPATOLOGY

Proton Pump Inhibitor Use and Enteric Infections

(2009) M Sandra Dial   AMERICAN JOURNAL OF GASTROENTEROLOGY

Oral Propranolol Decreases Intestinal Permeability in Patients With Cirrhosis: Another Protective Mechanism Against Bleeding?

(2009) Marco Senzolo et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Association of Proton Pump Inhibitor Therapy With Spontaneous Bacterial Peritonitis in Cirrhotic Patients With Ascites

(2009) Jasmohan S Bajaj et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Gastric acidity inhibitors and the risk of intestinal infections

(2009) Roberto Berni Canani et al.   CURRENT OPINION IN GASTROENTEROLOGY

63 Proton Pump Inhibitor (PPI) Use Is Independently Associated with Spontaneous Bacterial Peritonitis (SBP) in Cirrhotics with Ascites

(2009) William J. Bulsiewicz et al.   GASTROENTEROLOGY

Severe sepsis in cirrhosis

(2009) Thierry Gustot et al.   HEPATOLOGY

β-Blockers protect against spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis

(2009) Marco Senzolo et al.   LIVER INTERNATIONAL

Improved survival in patients receiving medical therapy as compared with banding ligation for the prevention of esophageal variceal rebleeding

(2008) Gin-Ho Lo et al.   HEPATOLOGY

Bacterial Infections, Sepsis, and Multiorgan Failure in Cirrhosis

(2008) Puneeta Tandon et al.   SEMINARS IN LIVER DISEASE

Proton pump inhibitors in cirrhosis: Tradition or evidence based practice?

(2008) Francesca Lodato et al.   WORLD JOURNAL OF GASTROENTEROLOGY